Sunflower Pharmaceutical Group (002737.SZ): Pediatric pulmonary heat cough and wheezing oral solution approved for clinical trials.
Sunflower Pharmaceutical Industry (002737.SZ) announced that its wholly-owned subsidiary, Heilongjiang Sunflower Pharmaceutical Co., Ltd., recently...
Sunflower Pharmaceutical Group (002737.SZ) announced that its wholly-owned subsidiary, Heilongjiang Sunflower Pharmaceutical Group Co., Ltd., recently received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration for the oral solution of pediatric pulmonary heat and cough asthma, allowing the product to conduct clinical trials for acute bronchitis in children.
Related Articles
BIOCYTOGEN-B(02315): Approved by the China Securities Regulatory Commission for A-share issuance registration.
Guotou Fengle (000713.SZ) successfully passes the Shenzhen Stock Exchange's review for its private placement of shares.
Hunan Silver (002716.SZ) plans to carry out real estate development on two self-owned lands in Chenzhou.
BIOCYTOGEN-B(02315): Approved by the China Securities Regulatory Commission for A-share issuance registration.
Guotou Fengle (000713.SZ) successfully passes the Shenzhen Stock Exchange's review for its private placement of shares.
Hunan Silver (002716.SZ) plans to carry out real estate development on two self-owned lands in Chenzhou.
